ESH International Conference Myelodysplastic Syndromes
Webcasted Presentations

Search’n Build™

Henrik Hasle  

Childhood MDS and JMML; biology, diagnosis, and treatment
2009-10-22 - English


Anna Porwit  

Diagnosis and WHO 2008 classification of MDS
2009-10-22 - English


Brigitte Schlegerberger  

Cytogenetics and molecular genetics in MDS
2009-10-22 - English


Arjan Van de Loosdrecht  

Case: Flow cytometry in myelodysplastic syndromes
2009-10-22 - English


David Bowen  

Epidemiology
2009-10-23 - English


Martin Jädersten  

Clinical presentation
2009-10-23 - English

Overiew of the presenting symptoms and diagnostic challenges of MDS.

Martin Jädersten  

Case
2009-10-23 - English

Interesting case of high-risk MDS with severe inflammatory symptoms. The inflammatory symptoms responded to 5-AZA treatment.

David Bowen  

Chronic myelomonocytic leukaemia
2009-10-23 - English


Joop Jansen  

TET2 mutations in MDS and MPNs
2009-10-23 - English


Pierre Fenaux  

Therapy related MDS
2009-10-23 - English


Rose Ann Padua  

Animal models - genetically modified mice
2009-10-23 - English


S. Boehrer  

Clonal evolution and leukaemic transformation
2009-10-24 - English


Pierre Fenaux  

Treatment of 5q-; the pro-lenalidomide view
2009-10-24 - English


Martin Jädersten  

Treatment of 5q-; the con-lenalidomide view
2009-10-24 - English

To understand the data underlying the decision of the EMEA not to approve lenalidomide for the treatment of MDS with isolated del(5q) in Europe.

ROSE Christian  

Treatment of transfusion iron overload in MDS; the pro-chelation view
2009-10-24 - English


David Bowen  

Treatment of transfusion iron overload in MDS; the con-chelation view
2009-10-24 - English


Guillermo Garcia Manero  

Management and treatment of thrombocytopenia
2009-10-24 - English


Pierre Fenaux  

Azacytidine in MDS
2009-10-25 - English


Guillermo Garcia Manero  

High-risk MDS: HIDACi and ongoing trials at clinical trials.gov
2009-10-25 - English